KR20200022771A - An anti-drunkenness and hangover-alleviating composition and its preparation method - Google Patents

An anti-drunkenness and hangover-alleviating composition and its preparation method Download PDF

Info

Publication number
KR20200022771A
KR20200022771A KR1020180098822A KR20180098822A KR20200022771A KR 20200022771 A KR20200022771 A KR 20200022771A KR 1020180098822 A KR1020180098822 A KR 1020180098822A KR 20180098822 A KR20180098822 A KR 20180098822A KR 20200022771 A KR20200022771 A KR 20200022771A
Authority
KR
South Korea
Prior art keywords
total
extract
hangover
flavanone
total flavanone
Prior art date
Application number
KR1020180098822A
Other languages
Korean (ko)
Inventor
자둥 린
Original Assignee
랜기어 테크놀러지 씨오. 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 랜기어 테크놀러지 씨오. 엘티디 filed Critical 랜기어 테크놀러지 씨오. 엘티디
Priority to KR1020180098822A priority Critical patent/KR20200022771A/en
Publication of KR20200022771A publication Critical patent/KR20200022771A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/24Non-sugar sweeteners
    • A23V2250/262Stevioside
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/50Polysaccharides, gums
    • A23V2250/51Polysaccharide
    • A23V2250/5112Cyclodextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/50Polysaccharides, gums
    • A23V2250/51Polysaccharide
    • A23V2250/5114Dextrins, maltodextrins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an anti-drunkenness and hangover-alleviating composition, and to a production method thereof. The anti-drunkenness and hangover-alleviating composition comprises a main ingredient containing at least one selected from a total flavanone extract of Polygonum multiflorum, a total flavanone extract of Rhizoma corydalis, and a total flavanone extract of Ophiopogon japonicas.

Description

항-주취 및 숙취-완화 조성물 및 그 제조 방법{An anti-drunkenness and hangover-alleviating composition and its preparation method}Anti-drunkenness and hangover-alleviating composition and its preparation method

본 발명은 의약 분야에 관한 것으로서, 특히 항-주취 및 숙취-완화 기능을 갖는 조성물 및 그 제조 방법에 관한 것이다.TECHNICAL FIELD The present invention relates to the field of medicine, and more particularly, to a composition having an anti-drinking and hangover-relaxing function and a method for producing the same.

보통 음주는 사람들의 신체 건강에 도움이 된다. 그러나, 과도한 음주는 주취(drunkenness) 및 현기증, 두통, 숙취, 및 음주 후 나쁜 품행을 초래하고, 정상 업무 및 대인 관계에 영향을 줄 수 있다. 더 심각한 것은 과도한 음주가 신체 조직과 장기를 손상시킬 수 있다는 것이다. 예를 들면, 연속적인 과도한 음주는 간 세포를 손상시키고 간의 정상적인 신진 대사를 방해할 수 있고, 알코올성 간염 및 간경변을 더욱 초래할 수 있다. 또한, 잦은 음주는 알코올 의존을 초래할 수 고, 이는 말하자면, 알코올 금단 증후군으로 불리는, 갑자기 음주를 중단하거나 또는 알코올 섭취를 줄인 후의 다양한 불편한 신체 증상이 나타날 것이다.Drinking alcohol usually helps people's physical health. However, excessive drinking can lead to drunkiness and dizziness, headaches, hangovers, and bad behavior after drinking and can affect normal work and interpersonal relationships. More seriously, excessive drinking can damage body tissues and organs. For example, continuous excessive drinking can damage liver cells, interfere with normal metabolism of the liver, and further lead to alcoholic hepatitis and cirrhosis. In addition, frequent drinking may result in alcohol dependence, which, as it were, will lead to various uncomfortable physical symptoms, such as alcohol withdrawal syndrome, after suddenly stopping drinking or reducing alcohol consumption.

따라서, 사람들은 음주로 인한 불편함을 완화하기 위해 다양한 방법을 채택하고 있고, 시장에 판매중인 많은 대응 제품도 있다; 그러나 대부분의 제품은 부정확한 치료 효과가 있다.Thus, people are adopting various methods to alleviate the discomfort associated with drinking, and there are many corresponding products on the market; However, most products have inaccurate therapeutic effects.

상기 문제점을 해결하기 위해, 본 발명은 다수의 실험에 기초한 새로운 항-주취 및 숙취-완화 조성물을 제안한다. 상기 조성물은 음주자의 주취 임계값(drunkenness threshold value)을 유의적으로 향상시키고, 주취 및 주취로 인하여 초래된 현기증, 통제 불능 행동 등의 신체 불편함을 방지하고, 대상자의 알코올 금단 증후군을 완화시킬 수 있다. 또한, 상기 조성물은 알코올의 분해를 촉진하고 간세포에서 알코올의 손상을 완화시킬 수 있는 간 보호 성분을 포함하고, 이상적인 항-주취 및 숙취-완화 제품이다.In order to solve the above problem, the present invention proposes a new anti-fragrance and hangover-releasing composition based on a number of experiments. The composition can significantly improve the alcoholic beverage threshold (drunkenness threshold value), prevent bodily discomfort such as dizziness, uncontrollable behavior caused by alcohol and alcohol, and relieve alcohol withdrawal syndrome of the subject have. In addition, the compositions include liver protective ingredients that can promote the breakdown of alcohol and mitigate the damage of alcohol in hepatocytes, and are ideal anti-drink and hangover-relieving products.

상기 기술적 목적을 달성하기 위해, 본 발명은 다음 기술적 방안을 채택한다:In order to achieve the above technical object, the present invention adopts the following technical solution:

적하수오 (Polygonum multiflorum) 총 플라바논 추출물 (total flavanone extract), 현호색 (Rhizoma corydalis) 총 플라바논 추출물 및 소엽맥문동 (Ophiopogon japonicus) 총 플라바논 추출물로부터 선택된 하나 이상을 함유하는 주요 성분을 포함하는, 항-주취 및 숙취-완화 조성물.Anti-gonist, comprising a major component comprising one or more selected from Polygonum multiflorum total flavanone extract, Rhizoma corydalis total flavanone extract, and Ophiopogon japonicus total flavanone extract Alcohol and Hangover-Relieving Compositions.

바람직하게는, 중량부 당, 적하수오 총 플라바논 추출물 0-40, 현호색 총 플라바논 추출물 0-40 및 소엽맥문동 총 플라바논 추출물 20-100을 포함하는, 주요 성분.Preferably, per part by weight, comprising a total amount of Daffodil total flavanone extract 0-40, corydalis total flavanone extract 0-40 and leaflet vegetation total flavanone extract 20-100.

바람직하게는, 상기 적하수오 총 플라바논 추출물 내 총 플라바논 함량은 >50%, 현호색 총 플라바논 추출물 내 총 플라바논 함량은 >80%, 및 소엽맥문동 총 플라바논 추출물 내 총 플라바논 함량은 >80% 이다.Preferably, the total flavanone content in the dropwise total flavanone extract is> 50%, the total flavanone content in corydalis total flavanone extract is> 80%, and the total flavanone content in the leaflet vegetation total flavanone extract is> 80%.

상기 적하수오 총 플라바논 추출물, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물은 다음 방법에 의해 제조된다:The Total Drainage Total Flavanone Extract, Corydalis Radix Total Flavanone Extract and Leaflet Vegetation Total Flavanone Extract are prepared by the following method:

상기 적하수오, 현호색 및 소엽맥문동을 분쇄함; 물 또는 70% 미만 농도의 에탄올로 상기 분쇄된 산물을 각각 추출함; 상기 추출된 용액을 회수함; 원심분리함; 추출, 매크로포러스 수지 칼럼 크로마토그래피 또는 재결정화를 수행함; 40-50 ℃에서 진공 건조함; 및 각 추출물의 함량이 요구 사항을 충족하는지 확인하는 검출함.Pulverizing the drip, scallop and leaflet veins; Extracting each of the milled products with water or ethanol at a concentration of less than 70%; Recovering the extracted solution; Centrifuge; Performing extraction, macroporous resin column chromatography or recrystallization; Vacuum dried at 40-50 ° C .; And detecting that the content of each extract meets the requirements.

본 발명의 항-주취 및 숙취-완화 조성물은 β-사이클로덱스트린, 말토덱스트린 및 스테비오시드로부터 선택된 하나 이상을 함유하는 보조 성분을 더욱 포함한다.The anti-fragrance and hangover-releasing composition of the present invention further comprises an auxiliary component containing at least one selected from β-cyclodextrin, maltodextrin and stevioside.

바람직하게는, 상기 주요 성분 및 보조 성분의 중량비는 1:(0-3) 이다.Preferably, the weight ratio of the main and auxiliary components is 1: (0-3).

본 발명은 또한, 다음 단계를 포함하는, 항-주취 및 숙취-완화 조성물을 제조하는 방법을 개시한다:The present invention also discloses a method of preparing an anti-drunken and hangover-relaxing composition comprising the following steps:

(1) 적하수오, 현호색 및 소엽맥문동을 분쇄함; 물 또는 70% 미만 농도의 에탄올로 상기 분쇄된 산물을 각각 추출함; 상기 추출된 용액을 회수함; 원심분리함; 추출, , 침전, 매크로포러스 수지 크로마토그래피 또는 재결화를 수행함; 40-50 ℃에서 진공 건조함; 각 추출물의 함량이 요구 사항을 충족하는지 확인하는 검출하여, 상기 적하수오 총 플라바논 추출물, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물을 수득함; 및 각 추출물을 분쇄하고, 60-메쉬 체로 거름; (1) crushed drip, sesame and leaflet veins; Extracting each of the milled products with water or ethanol at a concentration of less than 70%; Recovering the extracted solution; Centrifuge; Performing extraction, precipitation, macroporous resin chromatography or recrystallization; Vacuum dried at 40-50 ° C .; Detecting that the content of each extract satisfies the requirements, to obtain the above-mentioned drop total gland flavanone extract, corydalis gland total flavanone extract and leaflet vegetation total flavanone extract; And milling each extract and sieving with a 60-mesh sieve;

(2) 중량부 당, 상기 적하수오 총 플라바논 추출물 0-40, 소엽맥문동 총 플라바논 추출물 0-40, 및 소엽맥문동 총 플라바논 추출물 20-100 칭량하고, 그들을 균일하게 혼합하여 주요 성분을 수득함;(2) Per 1 part by weight, weighing 20 to 100 parts of the total dropwise total flavanone extract, 0-40 of the leaflet vegetation extract, and 20-100 of the leaflet vegetation extract, and mixing them uniformly to obtain the main components. box;

(3) 중량부 당, β-사이클로덱스트린 0-100 및 말토덱스트린 0-100, 칭량하고, 그들을 주요 성분과 균일하게 혼합하고, 총 중량 대비 10-50% 물 추가하고 반복적으로 연마, 진공 건조, 분쇄, 및 60-메쉬 체로 거름; 및(3) per part by weight, β-cyclodextrin 0-100 and maltodextrin 0-100, weighed, mixed them uniformly with the main ingredients, added 10-50% water to the total weight and repeatedly polished, vacuum dried, Grinding, and manure with a 60-mesh sieve; And

(4) 0-20 중량부의 스테비오시드 추가, 균일하게 혼합, 멸균, 펠렛화, 및 캡슐, 타블렛 또는 연질약으로 제조함.(4) 0-20 parts by weight of stevioside added, uniformly mixed, sterilized, pelletized, and prepared into capsules, tablets or soft medicines.

본 발명에서 기술된 항-주취 및 숙취-완화 조성물은 소엽맥문동을 포함하고, 보조 성분으로 적하수오 및 소엽맥문동을 주요 구성으로 포함한다. 지원자들에 대한 효과에 대한 관찰에 기초하여, 상기 항-주취 및 숙취-완화 조성물은 주취 임계값을 개선하고, 주취 증상을 완화시키거나 감소시키는 효과가 있음이 입증되었다.The anti-fragrance and hangover-relaxing compositions described in the present invention comprise the leaflet vein sinus and the main component of the dropping sesame and leaflet vein sinus as main components. Based on observations on the effect on volunteers, the anti-drunken and hang-over compositions have been demonstrated to have an effect of improving the alcohol threshold and alleviating or reducing the symptoms of alcohol.

이하, 구체적인 실시예와 조합하여 본 발명을 더욱 설명하지만, 본 발명은 이들 실시예에 제한되지 않는다.Hereinafter, the present invention is further described in combination with specific examples, but the present invention is not limited to these examples.

실시예 1Example 1

적하수오 총 플라바논 추출물, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물의 제조Preparation of Dripping Sewage Total Flavanone Extract, Corydalis Total Flavanone Extract, and Lobules Leaflet Total Flavanone Extract

목적하는 적하수오 총 플라바논 추출물은 적하수오를 분쇄함; 상기 분쇄된 적하수오를 60% 에탄올로 가열 환류 추출함; 상기 추출된 용액을 회수함; 원심분리함; 상기 상청액을 수집함; 매크로포러스 수지 크로마토그래피를 수행하여 총 플라본 농축 부분을 수득함; 용매를 회수함; 농축함; 40-50 ℃에서 진공 건조함; 및 총 플라본 함량이 >50% 임을 확인하는 검출함에 의해 제조된다. Desired dripping total flavanone extracts pulverized dripping; Heating and refluxing the ground dropwise water with 60% ethanol; Recovering the extracted solution; Centrifuge; Collecting the supernatant; Performing macroporous resin chromatography to obtain a total flavone enriched portion; Recovering the solvent; Concentrated; Vacuum dried at 40-50 ° C .; And detecting to confirm that the total flavone content is> 50%.

목적하는 현호색 총 플라바논 추출물은 현호색을 분쇄함; 상기 분쇄된 현호색을 40% 에탄올로 초음파 추출함; 상기 추출된 용액을 회수함; 원심분리함; 상기 상청액을 수집함; 에틸 아세테이트로 추출 수행하여 총 플라본 농축 부분을 수득함; 용매를 회수함; 농축함; 40-50 ℃에서 진공 건조함; 및 총 플라본 함량이 >80% 임을 확인하는 검출함에 의해 제조된다.Desired corydalis total flavanone extracts pulverize corydalis; Ultrasonically extracting the ground corydale with 40% ethanol; Recovering the extracted solution; Centrifuge; Collecting the supernatant; Extraction with ethyl acetate to give the total flavone concentrate portion; Recovering the solvent; Concentrated; Vacuum dried at 40-50 ° C .; And detecting to confirm that the total flavone content is> 80%.

목적하는 소엽맥문동 총 플라바논 추출물은 소엽맥문동을 분쇄함; 상기 분쇄된 소엽맥문동을 60% 에탄올로 가열 환류 추출함; 상기 추출된 용액을 회수함; 원심분리함; 상기 상청액을 수집함; 재결정화를 수행하여 플라본 농축 부분을 수득함; 40-50 ℃에서 진공 건조함; 및 총 플라본 함량이 >80% 임을 확인하는 검출함에 의해 제조된다. Desired leaflet vein pulmonary total flavanone extract pulverize leaflet vein sinus; Extracting the pulverized leafy veins from the heated reflux with 60% ethanol; Recovering the extracted solution; Centrifuge; Collecting the supernatant; Recrystallization is performed to obtain a flavone concentrate portion; Vacuum dried at 40-50 ° C .; And detecting to confirm that the total flavone content is> 80%.

실시예 2Example 2

항-주취 및 숙취-완화 캡슐은, 적하수오 총 플라바논 추출물, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물을 주요 성분으로 포함하고, 및 β-사이클로덱스트린을 보조 성분으로 포함하고 및 다음 단계를 통해 제조된다:The anti-drunken and hangover-relieving capsules contain a total of flavonoid extract, corydale total flavanone extract, and leaflet vegetation total flavanone extract as main components, and β-cyclodextrin as a secondary component and the next step. Is manufactured through:

(1) 실시예 1에서 제조된 500g의 칡(Puerariae lobatae) 총 플라바논 추출물, 500g의 현호색 총 플라바논 추출물 및 5000g의 소엽맥문동 총 플라바논 추출물을 칭량, 분쇄, 60-메쉬 체로 거름; 및 4000g의 β-사이클로덱스트린을 칭량하고, 상기 물질들을 균일하게 혼합함. (1) 500 g of Puerariae lobatae total flavanone extract prepared in Example 1, 500 g of corydalis total flavanone extract and 5000 g of lobular vegetation total flavanone extract were weighed, pulverized and filtered through a 60-mesh sieve; And 4000 g of β-cyclodextrin and mixing the materials uniformly.

(2) 3000ml의 물을 추가, 반복적으로 연마, 물 함량이 <5% 될때까지 40-50 ℃에서 진공 건조, 분쇄, 및 60-메쉬 체로 거름;(2) 3000 ml of water was added, repeatedly polished, vacuum dried at 40-50 ° C. until the water content was <5%, pulverized, and sieved through a 60-mesh sieve;

(3) 멸균 수행 후, 20-40% 습도 환경 하에서 펠렛화하여, 20-40 메쉬의 입자를 수득함; 및 (3) after sterilization, pelleted under 20-40% humidity environment to obtain 20-40 mesh of particles; And

(4) 50% 이하의 습도 환경 하에서 상기 입자를 캡슐 내로 충진하여, 각 중량 0.5g을 갖는, 캡슐을 수득함.(4) Filling the particles into capsules under a humidity environment of 50% or less, to obtain capsules having a weight of 0.5 g each.

투여 방법 및 투여량 : 경구 투여, 매회 두 캡슐, 음주 30 분 전에 따뜻한 물과 함께 투여.Method of administration and dosage: Oral administration, two capsules each time, with warm water 30 minutes before drinking.

실시예 3Example 3

항-주취 및 숙취-완화 연질약은, 소엽맥문동 총 플라바논 추출물을 주요 성분으로 포함하고, β-사이클로덱스트린, 말토덱스트린 및 스테비오시드를 보조 성분으로 포함하고; 및 다음 단계를 통해 제조된다:Anti-drinking and hangover-softening drugs include leaflet vegetation total flavanone extract as a main component and β-cyclodextrin, maltodextrin and stevioside as auxiliary components; And by the following steps:

(1) 실시예 1에서 제조된 5000g의 소엽맥문동 총 플라바논 추출물을 칭량하고, 5000g의 β-사이클로덱스트린 및 5000g의 말토덱스트린을 칭량하고, 상기 물질들을 균일하게 혼합함. (1) Weigh 5000 g of the leaflet vegetation total flavanone extract prepared in Example 1, weigh 5000 g of β-cyclodextrin and 5000 g maltodextrin, and mix the materials uniformly.

(2) 5000ml의 물을 추가, 반복적으로 연마, 물 함량이 <5% 될 때까지 40-50 ℃에서 진공 건조, 분쇄, 및 60- 메쉬 체로 거름;(2) 5000 ml of water is added, repeatedly polished, vacuum dried at 40-50 ° C. until the water content is <5%, pulverized, and filtered with a 60-mesh sieve;

(3) 1000g의 스테비오시드를 추가, 균일하게 혼합, 멸균 수행 후, 20-40% 습도 환경 하에서 펠렛화하여, 20-40 메쉬의 입자를 수득함; 및 (3) 1000 g of stevioside was added, mixed uniformly, and sterilized before being pelletized in a 20-40% humidity environment to obtain 20-40 mesh of particles; And

(4) 50% 이하의 습도 환경 하에서 상기 입자를 백(bag) 내로 충진하여, 각 중량 2g 을 갖는, 열질약을 수득함.(4) Filling the particles into a bag under a humidity environment of 50% or less, to obtain a thermotropic drug having a weight of 2 g each.

투여 방법 및 투여량 : 경구 투여, 매회 두 백, 음주 30 분 전 또는 음주 후에 (연질약이 끓인 물에 의해 용해된 이후에) 투여.Method of administration and dosage: Oral administration, two bags each time, 30 minutes before drinking or after drinking (after the soft medicine is dissolved in boiled water).

실시예 4Example 4

항-주취 및 숙취-완화 타블렛은, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물을 주요 성분으로 포함하고, 및 β-사이클로덱스트린 및 말토덱스트린을 보조 성분으로 포함하고; 및 다음 단계를 통해 제조된다:Anti-drunken and hangover-relieving tablets comprise corydalis total flavanone extract and leaflet vegetation total flavanone extract as main components, and β-cyclodextrin and maltodextrin as auxiliary components; And by the following steps:

(1) 실시예 1에서 제조된 300g의 현호색 총 플라바논 추출물 및 2500g의 소엽맥문동 총 플라바논 추출을 칭량함; 및 2500g의 β-사이클로덱스트린 및2500g의 말토덱스트린을 칭량하고, 및 상기 물질들을 균일하게 혼합함. (1) Weigh 300 g of Corydalis gland total flavanon extract and 2500 g of leaflet vegetation total flavanone extract prepared in Example 1; And 2500 g of β-cyclodextrin and 2500 g maltodextrin, and mixing the materials uniformly.

(2) 멸균 수행 후, 20-40% 습도 환경 하에서 펠렛화하여, 20-40 메쉬의 입자를 수득함; 및 타정하여 각 중량 0.3g 을 갖는 타블렛을 수득함. (2) after sterilization, pelleted under 20-40% humidity environment to obtain 20-40 mesh of particles; And tableting to give tablets having a weight of 0.3 g each.

투여 방법 및 투여량 : 경구 투여, 매회 2-3 타블렛, 음주 30 분 전 또는 음주 후에 투여.Method of administration and dosage: Oral administration, 2-3 tablets each time, 30 minutes before or after drinking.

실험 실시예 1Experimental Example 1

실시예 2에서 제조된 항-주취 숙취-완화 캡슐의 효과 관찰Observation of the Effect of the Anti-Drunk Hangover-Relieving Capsules Prepared in Example 2

캡슐은 30 명의 지원자에 의해 실험되었다. 그들은 음주 30 분 전에 두 캡슐씩 투여받았고, 음주 후 현기증과 주취 증상이 관찰되었다. 30 명의 지원자 모두가 다음의 피드백을 주었다: 캡슐이 효과적이었고, 음주자의 주취를 초래하는 알코올의 양을 유의적으로 증가시키고, 주취 및 주취에 의해 초래되는 현기증 및 행동 제어 상실과 같은 신체 불편함을 예방할 수 있다. 전형적인 실시예는 다음과 같다:Capsules were tested by 30 volunteers. They were given two capsules 30 minutes before drinking and dizziness and intoxication were observed after drinking. All 30 volunteers gave the following feedback: The capsules were effective, significantly increased the amount of alcohol causing alcohol intoxication, and increased physical discomfort such as dizziness and loss of behavioral control caused by alcohol and intoxication. It can be prevented. Typical examples are as follows:

매우 소량의 맥주를 마신 후 보통 현기증을 앓는 (셴 (Shen)이라는 성을 가진) 40 세의 남성 지원자는, 음주 30 분 전에 캡슐 두 개를 투여받았고, 100g의 52% 백포도주를 마신 후 현기증을 느끼지 않았다.A 40-year-old male volunteer (who has a last name, Shen) who drank a very small amount of beer, received two capsules 30 minutes before drinking and felt dizzy after drinking 100g of 52% white wine Did.

네 병의 맥주를 마신 후 보통 현미경을 앓는 (푸 (Fu)라는 성을 가진) 22 세의 남성 지원자는, 음주 30 분 전에 캡슐 두 개를 투여받았고, 일곱 병의 맥주를 마신 후 현기증을 느끼지 않았다.A 22-year-old male volunteer (with a surname named Fu) who usually suffered from a microscope after drinking four bottles of beer, received two capsules 30 minutes before drinking, and did not feel dizzy after drinking seven bottles of beer .

실험 실시예 2Experimental Example 2

실시예 3에서 제조된 항-주취 숙취-완화 연질약의 효과 관찰Observation of the effects of the anti-drunken hangover-softening agent prepared in Example 3

연질약은 5 명의 지원자에 의해 실험되었다. 그들은 음주에 의해 초래되는 현기증을 느낀 후 두 백의 연질약을 투여받았고, 현기증 증상에 대한 완화 효과가 관찰되었다. 5 명의 지원자 모두가 다음의 피드백을 주었다: 상기 연질약은 효과적이었고, 현기증 증상을 완화하고 주취 시간을 단축시킬 수 있었다.Soft pills were tested by five volunteers. After receiving dizziness caused by drinking, they received two hundred soft pills, and a mitigating effect on dizziness symptoms was observed. All five volunteers gave the following feedback: The soft medication was effective and could alleviate the dizziness symptoms and shorten the infusion time.

실험 실시예 3Experimental Example 3

실시예 4에서 제조된 항-주취 숙취-완화 타블렛의 효과 관찰Observing the Effect of the Anti-Drunk Hangover-Relieving Tablet Prepared in Example 4

캡슐은 16 명의 지원자에 의해 실험되었다. 그들은 음주 30 분 전에 두 캡슐씩 투여받았고, 음주 후 현기증 및 주취 증상이 관찰되었다. 그들 중, 15 명의 지원자가 다음의 피드백을 주었다: 타블렛이 효과적이었고, 음주자의 주취를 초래하는 알코올의 양을 유의적으로 증가시키고, 주취 및 주취에 의해 초래되는 현기증 및 행동 제어 상실과 같은 신체 불편함을 예방할 수 있다. 전형적인 실시예는 다음과 같다:Capsules were tested by 16 volunteers. They were given two capsules 30 minutes before drinking and dizziness and intoxication were observed after drinking. Of them, 15 volunteers gave the following feedback: The tablet was effective, significantly increased the amount of alcohol causing alcohol intoxication, and physical discomfort such as dizziness and loss of behavioral control caused by alcohol and intoxication Can be prevented. Typical examples are as follows:

보통 많은 알코올을 마시고 이내 현기증을 앓는 (가오 (Gao)라는 성을 가진) 31 세의 남성 지원자는, 음주 30 분 전에 타블렛 두 개를 투여받았고, 100g의 52% 백포도주를 마신 후 현기증을 느끼지 않았다.A 31-year-old male volunteer (usually named Gao) who drank a lot of alcohol and soon became dizzy, did not feel dizzy after drinking two tablets 30 minutes before drinking and 52% white wine.

보통 최대 한 병의 맥주를 마신 후 현기증을 앓고 백포도주를 마시지 않는 (장 (Zhang)이라는 성을 가진) 36 세의 남성 지원자는, 음주 30 분 전에 타블렛 두 개를 투여받았고, 100g의 52% 백포도주를 마신 후 현기증을 느끼지 않았다.A 36-year-old male volunteer (who has a surname called Zhang) who is dizzy and doesn't drink white wine after drinking up to one bottle of beer, received two tablets 30 minutes before drinking, and received 100g of 52% white wine. Did not feel dizzy after drinking.

Claims (7)

적하수오 (Polygonum multiflorum) 총 플라바논 추출물, 현호색 (Rhizoma corydalis) 총 플라바논 추출물 및 소엽맥문동 (Ophiopogon japonicas) 총 플라바논 추출물으로부터 선택된 하나 이상을 함유하는 주요 성분을 포함하는, 항-주취 및 숙취-완화 조성물.Anti-Drunk and Hangover-Containing a major ingredient comprising at least one selected from Polygonum multiflorum total flavanone extract, Rhizoma corydalis total flavanone extract and Ophiopogon japonicas total flavanone extract Emollient composition. 제1항에 있어서, 상기 주요 성분은, 중량부 당, 적하수오 총 플라바논 추출물 0-40, 현호색 총 플라바논 추출물 0-40 및 소엽맥문동 총 플라바논 추출물 20-100을 포함하는 항-주취 및 숙취-완화 조성물.According to claim 1, wherein the main ingredient, anti-fraction including a total weight of flavanone extract 0-40, sage red total flavanone extract 0-40 and leaflet vegetation total flavanone extract 20-100 per weight part; Hangover-relaxing composition. 제1항 또는 제2항에 있어서, 상기 적하수오 총 플라바논 추출물 내 총 플라바논 함량은 >50%, 현호색 총 플라바논 추출물 내 총 플라바논 함량은 >80%, 소엽맥문동 총 플라바논 추출물 내 총 플라바논 함량은 >80%인 항-주취 및 숙취-완화 조성물.According to claim 1 or 2, wherein the total flavanone content in the total drop of the total flavanone extract is> 50%, total flavanone content in the corydalis total flavanone extract is> 80%, total leaf in the leaflet vegetation total flavanone extract Anti-fragrance and hangover-relaxing composition having a flavanone content of> 80%. 제3항에 있어서, 상기 적하수오 총 플라바논 추출물, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물은 다음 방법에 의하여 제조된 항-주취 및 숙취-완화 조성물:
상기 적하수오, 현호색 및 소엽맥문동을 분쇄함; 물 또는 70% 미만 농도의 에탄올로 상기 분쇄된 산물을 각각 추출함; 상기 추출된 용액을 회수함; 원심분리함; 추출, 매크로포러스 수지 칼럼 크로마토그래피 또는 재결정화를 수행함; 40-50 ℃에서 진공 건조함; 및 각 추출물의 함량이 요구 사항을 충족하는지 확인하는 검출함.
The anti-drinking and hangover-relaxing composition according to claim 3, wherein the total dropwise total flavanone extract, corydale total flavanone extract and leaflet vegetation total flavanone extract are prepared by the following method:
Pulverizing the drip, scallop and leaflet veins; Extracting each of the milled products with water or ethanol at a concentration of less than 70%; Recovering the extracted solution; Centrifuge; Performing extraction, macroporous resin column chromatography or recrystallization; Vacuum dried at 40-50 ° C .; And detecting that the content of each extract meets the requirements.
제3항에 있어서, β-사이클로덱스트린, 말토덱스트린 및 스테비오시드로부터 선택된 하나 이상을 함유하는 보조 성분을 더욱 포함하는 항-주취 및 숙취-완화 조성물.The anti-fragrance and hangover-relaxing composition of claim 3 further comprising an auxiliary component containing at least one selected from β-cyclodextrin, maltodextrin and stevioside. 제5항에 있어서, 상기 주요 성분 및 보조 성분의 중량비는 1:(0-3)인 항-주취 및 숙취-완화 조성물.The anti-fragrance and hangover-relaxing composition of claim 5 wherein the weight ratio of the main component and the auxiliary component is 1: (0-3). 다음 단계를 포함하는 항-주취 및 숙취-완화 조성물 제조방법:
(1) 적하수오, 현호색 및 소엽맥문동을 분쇄함; 물 또는 70% 미만 농도의 에탄올로 상기 분쇄된 산물을 각각 추출함; 상기 추출된 용액을 회수함; 원심분리함; 추출, 매크로포러스 수지 칼럼 크로마토그래피 또는 재결정화를 수행함; 40-50 ℃에서 진공 건조함; 각 추출물의 함량이 요구 사항을 충족하는지 확인하는 검출하여, 상기 적하수오 총 플라바논 추출물, 현호색 총 플라바논 추출물 및 소엽맥문동 총 플라바논 추출물을 수득함; 및 각 추출물을 분쇄하고, 60-메쉬 체로 거름;
(2) 중량부 당, 상기 적하수오 총 플라바논 추출물 0-40, 소엽맥문동 총 플라바논 추출물 0-40, 및 소엽맥문동 총 플라바논 추출물 20-100 칭량하고, 그들을 균일하게 혼합하여 주요 성분을 수득함;
(3) 중량부 당, β-사이클로덱스트린 0-100 및 말토덱스트린 0-100 칭량하고, 그들을 주요 성분과 균일하게 혼합하고, 총 중량 대비 10-50% 물 추가하고 반복적으로 연마, 진공 건조, 분쇄, 및 60-메쉬 체로 거름; 및
(4) 0-20 중량부의 스테비오시드 추가, 균일하게 혼합, 멸균, 펠렛화, 및 캡슐, 타블렛 또는 연질약으로 제조함.
A method for preparing an anti-drink and hangover-releasing composition comprising the following steps:
(1) crushed drip, sesame and leaflet veins; Extracting each of the milled products with water or ethanol at a concentration of less than 70%; Recovering the extracted solution; Centrifuge; Performing extraction, macroporous resin column chromatography or recrystallization; Vacuum dried at 40-50 ° C .; Detecting that the content of each extract satisfies the requirements, to obtain the above-mentioned dulciflora total flavanone extract, corydalis total flavanone extract and leaflet vegetation total flavanone extract; And milling each extract and sieving with a 60-mesh sieve;
(2) per weight part, weighing 20 to 100 drops of the total dropwise total flavanone extract, 0-40 of the leaflet vegetation extract, and 20-100 of the leaflet vegetation extract, and mixing them uniformly to obtain the main components. box;
(3) per part by weight, β-cyclodextrin 0-100 and maltodextrin 0-100 are weighed, mix them uniformly with the main ingredients, add 10-50% water to the total weight and repeat polishing, vacuum drying, grinding , And 60-mesh sieve; And
(4) 0-20 parts by weight of stevioside added, uniformly mixed, sterilized, pelletized, and prepared into capsules, tablets or soft medicines.
KR1020180098822A 2018-08-23 2018-08-23 An anti-drunkenness and hangover-alleviating composition and its preparation method KR20200022771A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180098822A KR20200022771A (en) 2018-08-23 2018-08-23 An anti-drunkenness and hangover-alleviating composition and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180098822A KR20200022771A (en) 2018-08-23 2018-08-23 An anti-drunkenness and hangover-alleviating composition and its preparation method

Publications (1)

Publication Number Publication Date
KR20200022771A true KR20200022771A (en) 2020-03-04

Family

ID=69783316

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180098822A KR20200022771A (en) 2018-08-23 2018-08-23 An anti-drunkenness and hangover-alleviating composition and its preparation method

Country Status (1)

Country Link
KR (1) KR20200022771A (en)

Similar Documents

Publication Publication Date Title
JP4413995B2 (en) Medicinal plant extract with anti-obesity effect
KR102615399B1 (en) A composition for the prevention or treatment of hepatitis C virus infection disease comprising a compound isolated from Agrimonia pilosa extract and Galla rhois extract
CN111803608A (en) A Chinese medicinal composition with antiviral effect
CN111011681A (en) Emblic leafflower fruit extract for dispelling effects of alcohol and protecting liver and preparation method and application thereof
CN102860552A (en) Process for preparing lotus leaf weight-reducing beverage
CN104815138A (en) Immature bitter orange extract, preparation and application
KR20200136207A (en) Composition for anti-allergy comprising extract of lithospermum erythrorhizon
KR20200009824A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
KR100824970B1 (en) Polygoni cuspidati radix extract for allergic disease and process for preparation thereof
KR20200022771A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
KR101537856B1 (en) A pharmaceutical composition for preventing and treating nonalcoholic fatty liver disease comprising extraction fraction with enhanced gincenoside rb1 from panax ginseng as an active ingredient
CN103830374A (en) Application of three-leaf glycolipid-removal medicine in hyperuricemia
KR20030080296A (en) Composition containing saponin fraction and derivatives isolated from ginseng radix for preventing and treating allergy-mediated disease
KR20180118413A (en) Composition comprising Cordycepin as an effective ingredient for preventing or treating of Liver cancer and Method for preparing Butanol fraction of Cordyceps militaris
KR20200020287A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
KR20230058792A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
CN110624006A (en) A health wine containing effective components of fructus Quzhazhii
CN104784371A (en) Pharmaceutical composition for resisting alcoholic liver injury and preparation method thereof
KR100533505B1 (en) Health supplement food containing saponin derivatives isolated from ginseng radix for preventing and treating allergy-mediated disease
KR20200004196A (en) An anti-drunkenness and hangover-alleviating composition and its preparation method
KR100750873B1 (en) A pharmaceutical composition comprising the extract of Rubiae Radix for treating or preventing allergic disease
EP1498131B1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from Cistanche tubulosa
CN104585469A (en) Chewing gum having protective effect on alcoholic liver injury and preparation method of chewing gum
DE102019203483A1 (en) AN ANTI-DRUNK AND HANGOVER RELIEF COMPOSITION AND THEIR METHOD OF MANUFACTURING
JP2020007250A (en) Anti-drunkenness and hangover-mitigating composition, and method of preparing the same